These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8748623

  • 1. Changes in the amplitude of the N30 frontal component of SEPs during apomorphine test in parkinsonian patients.
    de Mari M, Margari L, Lamberti P, Iliceto G, Ferrari E.
    J Neural Transm Suppl; 1995; 45():171-6. PubMed ID: 8748623
    [Abstract] [Full Text] [Related]

  • 2. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave.
    Cheron G, Piette T, Thiriaux A, Jacquy J, Godaux E.
    Electroencephalogr Clin Neurophysiol; 1994 Nov; 92(6):491-501. PubMed ID: 7527767
    [Abstract] [Full Text] [Related]

  • 3. [Somatosensory evoked potentials and symptomatic response to dopaminergic drugs in Parkinson's disease].
    Castillo JL, Miranda CM, Araya F, Sáez D.
    Rev Med Chil; 1996 Mar; 124(3):301-6. PubMed ID: 9008941
    [Abstract] [Full Text] [Related]

  • 4. Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism.
    Rossini PM, Bassetti MA, Pasqualetti P.
    Electroencephalogr Clin Neurophysiol; 1995 May; 96(3):236-47. PubMed ID: 7750449
    [Abstract] [Full Text] [Related]

  • 5. N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study.
    Traversa R, Pierantozzi M, Semprini R, Loberti M, Cicardi MC, Bassi A, Stanzione P.
    J Neural Transm Suppl; 1995 May; 45():177-85. PubMed ID: 8748624
    [Abstract] [Full Text] [Related]

  • 6. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components.
    Rossini PM, Traversa R, Boccasena P, Martino G, Passarelli F, Pacifici L, Bernardi G, Stanzione P.
    Neurology; 1993 Dec; 43(12):2495-500. PubMed ID: 8255446
    [Abstract] [Full Text] [Related]

  • 7. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
    Kanovský P, Streitová H, Dufek J, Znojil V, Daniel P, Rektor I.
    Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
    [Abstract] [Full Text] [Related]

  • 8. Topographic MN-SSEPs (N18, N20 and N30) might characterize underlying CNS involvements in representative types of cerebral palsy.
    Tomita Y, Fukuda C, Kato Y, Maegaki Y, Shiota S, Amisaki T.
    Brain Dev; 2006 Nov; 28(10):653-9. PubMed ID: 16766152
    [Abstract] [Full Text] [Related]

  • 9. The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients.
    Pierantozzi M, Mazzone P, Bassi A, Rossini PM, Peppe A, Altibrandi MG, Stefani A, Bernardi G, Stanzione P.
    Clin Neurophysiol; 1999 Oct; 110(10):1700-7. PubMed ID: 10574285
    [Abstract] [Full Text] [Related]

  • 10. Abnormalities of somatosensory evoked potentials in spasmodic torticollis.
    Mazzini L, Zaccala M, Balzarini C.
    Mov Disord; 1994 Jul; 9(4):426-30. PubMed ID: 7969209
    [Abstract] [Full Text] [Related]

  • 11. Short-latency median nerve somatosensory evoked potentials in three cases of parkinsonism and dopa responsive dystonia.
    Margari L, de Mari M, Lamberti P, Iliceto G, Serlenga L, Perniola T, Rossini PM, Ferrari E.
    Funct Neurol; 1995 Jul; 10(2):99-105. PubMed ID: 7557558
    [Abstract] [Full Text] [Related]

  • 12. Somatosensory evoked potentials in migraine.
    de Tommaso M, Sciruicchio V, Tota P, Megna M, Guido M, Genco S, Puca F.
    Funct Neurol; 1997 Jul; 12(2):77-82. PubMed ID: 9238341
    [Abstract] [Full Text] [Related]

  • 13. Abnormality of N30 somatosensory evoked potentials in Parkinson's disease: a multidisciplinary approach.
    Bostantjopoulou S, Katsarou Z, Zafiriou D, Gerasimou G, Alevriadou A, Georgiadis G, Kiosseoglou G, Kazis A.
    Neurophysiol Clin; 2000 Dec; 30(6):368-76. PubMed ID: 11191929
    [Abstract] [Full Text] [Related]

  • 14. Frontal N30 of median nerve SSEPs for evaluation of movement disorders with destructive basal ganglia deficits.
    Fukuda C, Tomita Y, Maegaki Y, Kubota N.
    Neuropediatrics; 2003 Aug; 34(4):205-10. PubMed ID: 12973662
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes.
    Pierantozzi M, Sabato AF, Leonardis F, Marciani MG, Cicardi C, Giacomini P, Bernardi G, Stanzione P.
    Exp Brain Res; 2000 Aug; 133(3):368-76. PubMed ID: 10958527
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease.
    Mauguière F, Broussolle E, Isnard J.
    Electroencephalogr Clin Neurophysiol; 1993 Aug; 88(4):243-54. PubMed ID: 7688279
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.